BioMed Research International · 2016 · 54 citations · 27 references
MedicineNeurosciencePharmacologyChemotherapyCognitive NeuroscienceNeuropharmacologyCognitive ImpairmentMemory In AnimalsNeural Basis Of MemoryWorking MemoryCancer-related Cognitive ImpairmentChemotherapy-related Cognitive ImpairmentCognitive Effects Of ChemotherapyCognitive Impairment From ChemotherapyCognitive Impairment In CancerCognitive PerformanceCognitive Performance ImpairmentTreatment-related Neurocognitive Effects
A considerable number of patients with breast cancer complain of cognitive impairment after chemotherapy. In this study, we showed that donepezil enhanced memory function and increased brain glucose metabolism in a rat model of cognitive impairment after chemotherapy using behavioral analysis and positron emission tomography (PET). We found that chemotherapy affected spatial learning ability, reference memory, and working memory and that donepezil improved these cognitive impairments. According to PET analysis, chemotherapy reduced glucose metabolism in the medial prefrontal cortex and hippocampus, and donepezil increased glucose metabolism in the bilateral frontal lobe, parietal lobe, and hippocampus. Reduced glucose metabolism was more prominent after treatment with doxorubicin than cyclophosphamide. Our results demonstrated the neural mechanisms for cognitive impairment after chemotherapy and show that cognition was improved after donepezil intervention using both behavioral and imaging methods. Our results suggested that donepezil can be employed clinically for the treatment of cognitive deficits after chemotherapy.
27
Place navigation impaired in rats with hippocampal lesions
Richard Morris, Paul Garrud, J. N. P. Rawlins et al. · Nature · 1982 · 6.4K citations
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
Bengt Winblad, Knut Engedal, Hilkka Soininen et al. · Neurology · 2001 · 731 citations